Skip to content

The effect of cross linking on infectious corneal ulcer

Riboflavin-UV A chollagen crosslinking for treatment of recalcitrant infectious corneal ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105074166N3
Enrollment
10
Registered
2011-11-12
Start date
2011-08-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious corneal ulcers. Keratitis,Corneal ulcer

Interventions

Collagen cross linking with ultraviolet irradiation and riboflavin.
Treatment - Other
Collagen cross linking with ultraviolet irradiation and riboflavin

Sponsors

Vice-chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:Patients with infectious corneal ulcer ;with a size of more than 3 mm;with hypopyon ;hospitalized in Nikookari eye hospital ;who have received the maximal conventional treatment including fortified topical and subconjunctival antibiotics without appropriate response. Exclusion criteria:Patients with a history of crosslinking;significant corneal thinning and descematocele formation; cases of recurrent infection;herpetic ulcers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Epithelial defect. Timepoint: Before intervention, daily until full healing,2 months postintervention. Method of measurement: Evaluation with slit lamp with flouroscien, measurement in millimetres.;Infiltration. Timepoint: Before intervention, daily until full healing,2 months postintervention. Method of measurement: Evaluation with slit lamp , measurement in millimetres.;Hypopyon. Timepoint: Before intervention, daily until full healing,2 months postintervention. Method of measurement: Evaluation with slit lamp , measurement in millimetres.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRana Daii Sorkhabi

Nikookari eye hospital, Faculty of Medicine,Tabriz University of Medcal Sciences

rana@tbzmed.ac.ir; sorkhabi_r@yahoo.com+98 41 1657 7330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026